10-K/A: LivePerson 2025 Annual Report Amendment

LivePerson files an amendment to its 2025 Annual Report on Form 10-K to include required Part III disclosures regarding executive compensation and corporate governance.

Summary

• The filing is an amendment (Form 10-K/A) to the previously filed 2025 Annual Report.
• It provides mandatory disclosures for Items 10 through 14, which were omitted from the original filing.
• The document includes updated biographical information for directors and executive officers.
• It details executive compensation for the 2025 fiscal year for the CEO, CFO/COO, and Chief Technology & Product Officer.
• The filing confirms the company's compliance with Nasdaq and SEC corporate governance standards.
• It includes updated exhibits, including the Fourth Amended and Restated By-Laws and certifications from the CEO and CFO.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging period for the company, characterized by declining revenues, significant debt restructuring, and ongoing legal uncertainties, despite efforts to stabilize the balance sheet.

Positives

• Successful completion of a debt restructuring in September 2025, improving the capital structure.
• The company has maintained compliance with its financial covenants as of December 31, 2025.
• The board has been refreshed with new appointments, including directors with significant turnaround and SaaS experience.
• The company has successfully divested non-core assets like WildHealth and Kasamba to focus on its core digital conversation platform.

Negatives

• The company reported a net loss of $67.2 million for the fiscal year ended December 31, 2025.
• Total revenue declined to $243.7 million in 2025 from $312.5 million in 2024 and $402.0 million in 2023.
• The company recorded a non-cash goodwill impairment charge of $41.6 million in 2025.
• The company is subject to ongoing legal proceedings, including derivative actions and regulatory inquiries related to past COVID-19 testing services.

Risks

• Significant accumulated net losses and a history of negative cash flows.
• High debt levels and the potential for future defaults if financial covenants are not met.
• Dependence on the successful execution of its AI-powered conversation platform strategy.
• Potential for further goodwill or intangible asset impairment charges if financial performance does not meet expectations.
• Legal and regulatory risks, including ongoing litigation and government inquiries.

Future Outlook

The company focuses on its enterprise-class digital customer conversation platform, leveraging Generative AI and LLMs. Management aims to align the cost structure with current commercial performance while navigating debt obligations and ongoing legal matters.

Management Comments

• Management emphasizes the compatibility of existing customer investments in Generative AI with the LivePerson Platform.
• The company highlights the 'tango' of humans and AI to improve agent efficiency and relationship building.
• Management notes that the 2025 restructuring plan was initiated to reduce cash expenditures and align with current commercial performance.

Industry Context

StockSavvy.ai notes that LivePerson is operating in a highly competitive CCaaS and AI-driven customer engagement market, facing significant pressure to pivot toward profitable growth while managing a complex debt load and legacy legal issues.

Comparison to Industry Standards

• Revenue decline reflects broader industry challenges in the SaaS sector regarding enterprise spending and AI-driven transformation.
• The use of debt restructuring and reverse stock splits is consistent with companies attempting to stabilize their capital structure during periods of financial distress.
• The company's focus on Generative AI aligns with industry-wide trends, though it faces stiff competition from larger, better-capitalized incumbents.

Management Changes

Corporate Governance

Legal Proceedings

• Putative stockholder class action (Damri v. LivePerson, Inc.) remanded to district court for repleading.
• Multiple derivative actions (Marti, Steffens, Ravi, Morales, Perkins) stayed or in abeyance pending Damri case.
• Settlement of Starboard Value LP litigation in July 2025.
• Ongoing inquiries by Medicare, DOJ, and FDA regarding discontinued COVID-19 testing services.

Related Party Transactions

• Debt exchange transactions involving entities advised by Linden Advisors LP, Davidson Kempner Capital Management LP, and Palogic Value Fund, LP (affiliated with director Ryan Vardeman).

Stakeholder Impact

• Shareholders experienced a 1-for-15 reverse stock split.
• Creditors involved in the debt exchange received new notes and equity.
• Employees impacted by restructuring initiatives.

Next Steps

• Continued cooperation with governmental inquiries related to past COVID-19 testing services.
• Ongoing management of debt obligations and compliance with financial covenants.
• Execution of the 2025 restructuring plan to align costs with revenue.

Key Dates

Recommendation

The company is in a high-risk turnaround phase. While the debt restructuring provides some breathing room, the significant revenue decline and ongoing legal risks suggest a cautious 'hold' until there is clear evidence of operational stabilization and revenue growth.

Keywords

LivePerson, LPSN, SaaS, Generative AI, Debt Restructuring, Corporate Governance, Executive Compensation, 10-K/A